Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04MLU
|
||||
Former ID |
DNC010156
|
||||
Drug Name |
[1-(4-p-Tolyl-butyl)-piperidin-4-yl]-methanol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C17H27NO
|
||||
Canonical SMILES |
CC1=CC=C(C=C1)CCCCN2CCC(CC2)CO
|
||||
InChI |
1S/C17H27NO/c1-15-5-7-16(8-6-15)4-2-3-11-18-12-9-17(14-19)10-13-18/h5-8,17,19H,2-4,9-14H2,1H3
|
||||
InChIKey |
VTDHRHRPPVJGSU-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [1] | |
PathWhiz Pathway | Muscle/Heart Contraction | ||||
Reactome | Voltage gated Potassium channels | ||||
WikiPathways | SIDS Susceptibility Pathways | ||||
Hematopoietic Stem Cell Differentiation | |||||
Potassium Channels | |||||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2009 Sep 1;19(17):5043-7. Epub 2009 Aug 5.Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.